Physician profile
Roman Petroff
NPI 1477568863
$5,057.16
in general payments reported to CMS, 2019-2025
39 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $782 · 2021: $1,793 · 2022: $1,129 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $939.58 | 2019-2022 | |
| Pfizer INC. | $455.45 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $409.71 | 2019-2022 | |
| Amgen INC. | $394.48 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.66 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $252.67 | 2019-2023 | Eliquis |
| Amarin Pharma, INC. | $236.73 | 2019-2021 | |
| Novo Nordisk INC | $173.09 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $165.49 | 2020-2022 | |
| Lilly USA, LLC | $155.00 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.93 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $128.05 | 2020-2022 | |
| Celgene Corporation | $125.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $122.67 | 2019-2022 | |
| Allergan, INC. | $104.24 | 2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roman Petroff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.